1.
WHO | EARTHQUAKES - Technical Hazard Sheet - Natural Disaster Profile
EARTHQUAKES - Technical Hazard Sheet - Natural Disaster Profile. The Hazard. Earthquake can be defined as the shaking of earth caused by waves moving on and ...
2.
QSM/MC/IEA.116 23 July 2007 Information Exchange System Alert No. 116
File Format: PDF/Adobe Acrobat - View as HTML Jul 23, 2007 ... QSM/MC/IEA.116. 23 July 2007. Information Exchange System ... The European Medicines Agency (EMEA) has issued a Press Release recommending ...
3.
WHO | International Conference of Drug Regulatory Authorities
The International Conference of Drug Regulatory Authorities (ICDRAs) provide drug regulatory authorities of WHO Member States with a forum to meet and ...
4.
Proceedings of the Tenth International Conference of Drug ...
Professor Alfred Hildebrandt, Chair of the Ninth ICDRA, Germany · View the document · Dr Margaret Chan, Chair of the Tenth ICDRA Director of Health, ...
5.
WHO | Aluminium-containing vaccines and macrophagic myofasciitis (MMF)
Aluminium-containing vaccines and macrophagic myofasciitis (MMF). At present there is no evidence of a health risk from aluminium-containing vaccines or any ...
6.
ICD-10:
XXI, Z00-Z99, Factors influencing health status and contact with health services. XXII, U00-U99, Codes for special purposes ...
7.
Production of ICD-11: The overall revision process
File Format: PDF/Adobe Acrobat - View as HTML 4.3 Knowledge Management and Sharing Portal for ICD Revision. To facilitate communication among the members of the workgroups, and make the expert group ...
8.
WHO | Software tools
DISMOD II is a software tool that may be used to check the consistency of estimates of incidence, prevalence, duration and case fatality for diseases. ...
9.
WHO | Electromagnetic fields
Electromagnetic fields of all frequencies represent one of the most common and fastest growing environmental influences, about which anxiety and speculation ...
10.
WHO Pharmaceuticals Newsletter 2001, No. 02&03: REGULATORY MATTERS ...
Jan 19, 2009 ... existing QT interval prolongation (QTc = 500 ms) or factors which predispose the patient to QT interval prolongation. Treatment with ...
